FDA NDC Directory · JSON-LD · Markdown

Spironolactone and hydrochlorothiazide

NDC 72888-040 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAdvagen Pharma Ltd.
Marketing categoryAbbreviated NDA (generic) · App ANDA220884
Dosage form / routeTABLET · ORAL
Active ingredientsSPIRONOLACTONE (25 mg/1)
HYDROCHLOROTHIAZIDE (25 mg/1)
Marketing started20260910
Package count3

External sources

Source: openFDA. Public-domain (CC0).